Back
Pieris Pharmaceuticals 10K Form
Sell
45
PIRS
Pieris Pharmaceuticals
Last Price:
16.95
Seasonality Move:
9.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PIRS News And Ratings
See the #1 stock for the next 7 days that we like better than PIRS
PIRS Financial Statistics
Sales & Book Value
| Annual Sales: | $42.81M |
|---|---|
| Cash Flow: | $-1.48M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.17 |
| Price / Book: | 1.2 |
Profitability
| EPS (TTM): | -18.71000 |
|---|---|
| Net Income (TTM): | $-23.82M |
| Gross Margin: | $5.37M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Pieris Pharmaceuticals Earnings Forecast
Key Pieris Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 2 years for PIRS is 118.42%.
- The Selling, General & Administrative Expenses for PIRS have been equal to 39.37% of Gross Profit Margin.
- The Research & Development expenses have been 97.64% of Revenue.
- The Interest Expense is -1.28% of Operating Income.
- The Net Earning history of PIRS is -57.33% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
Pieris Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PIRS |
| CUSIP: | 720795 |
| Website: | pieris.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PIRS Technical Analysis vs Fundamental Analysis
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy or a Sell?
-
Pieris Pharmaceuticals stock is rated a Sell
The current Pieris Pharmaceuticals [PIRS] share price is $16.98. The Score for PIRS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.